aztreonam has been researched along with Ascites in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacokinetics of aztreonam were studied in six healthy male subjects (group I) and 12 male patients with post-hepatitis liver cirrhosis and ascites." | 7.68 | Pharmacokinetics of aztreonam in patients with liver cirrhosis and ascites. ( Abdel Barry, M; el Guinaidy, M; el Touny, M; Osman, L; Sabbour, MS, 1992) |
| "The pharmacokinetics of aztreonam were studied in six healthy male subjects (group I) and 12 male patients with post-hepatitis liver cirrhosis and ascites." | 3.68 | Pharmacokinetics of aztreonam in patients with liver cirrhosis and ascites. ( Abdel Barry, M; el Guinaidy, M; el Touny, M; Osman, L; Sabbour, MS, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| el Touny, M | 1 |
| el Guinaidy, M | 1 |
| Abdel Barry, M | 1 |
| Osman, L | 1 |
| Sabbour, MS | 1 |
1 other study available for aztreonam and Ascites
| Article | Year |
|---|---|
Pharmacokinetics of aztreonam in patients with liver cirrhosis and ascites.
Topics: Adult; Ascites; Ascitic Fluid; Aztreonam; Humans; Injections, Intravenous; Liver Cirrhosis; Male | 1992 |